General Information of Disease (ID: DISLVMWO)

Disease Name Mood disorder
Synonyms episodic mood disorder
Disease Class 6A60-6E23: Mood disorder
Definition A cognitive disorder a disturbance in which the person's mood is hypothesized to be the main underlying feature.
Disease Hierarchy
DIS3J5R8: Mental disorder
DISLVMWO: Mood disorder
ICD Code
ICD-11
ICD-11: 6A60-6E23
Disease Identifiers
MONDO ID
MONDO_0005371
MESH ID
D019964
UMLS CUI
C0525045
MedGen ID
99866
SNOMED CT ID
46206005

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 3 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Dasotraline DMLDQFV Approved Small molecular drug [1]
Flibanserin DM70DTN Approved Small molecular drug [2]
Vortioxetine DM6F1PU Approved Small molecular drug [3]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 19 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
ADX N05 DMLBYRA Phase 3 NA [4]
Amitifadine DMS1X67 Phase 3 Small molecular drug [5]
LITOXETINE DMKZRBP Phase 3 Small molecular drug [6]
NVP-LAQ824 DM8JWNA Phase 3 Small molecular drug [5]
ADX-48621 DM6GTMD Phase 2/3 Small molecular drug [7]
CX157 DMS2WB5 Phase 2 Small molecular drug [8]
GW 597599 DMY53PL Phase 2 Small molecular drug [9]
MN-305 DMUGN4B Phase 2 Small molecular drug [5]
NKP 608 DMTVGMZ Phase 2 NA [10]
NS 2359 DMI5HFU Phase 2 Small molecular drug [11]
OPC-14523 DMB1WF3 Phase 2 Small molecular drug [12]
ORG 34517/34850 DMR3P98 Phase 2 Small molecular drug [5]
TGBA01AD DMJ2FTU Phase 2 Small molecular drug [5]
TRIDMAC DMWU41P Phase 2 Small molecular drug [5]
JNJ-55308942 DM0QZJX Phase 1 NA [13]
MEM-1414 DMA1KQV Phase 1 NA [14]
ND7001 DMUBTC6 Phase 1 NA [15]
TC-2216 DM4W92J Phase 1 Small molecular drug [16]
[N-methyl-3H(3)]AZ-10419369 DMSCV02 Phase 1 Small molecular drug [17]
------------------------------------------------------------------------------------
⏷ Show the Full List of 19 Drug(s)
This Disease is Treated as An Indication in 16 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Amibegron DMPS14M Discontinued in Phase 3 Small molecular drug [18]
L-759274 DMXWRGF Discontinued in Phase 3 NA [5]
Adatanserin DMMKFUP Discontinued in Phase 2 Small molecular drug [5]
AMESERGIDE DMRY9V8 Discontinued in Phase 2 Small molecular drug [19]
BMS-181101 DMT4VSE Discontinued in Phase 2 Small molecular drug [20]
CP-316,311 DMZ76EM Discontinued in Phase 2 Small molecular drug [21]
DOV-216303 DMTE14H Discontinued in Phase 2 Small molecular drug [5]
DU 125530 DM63UA9 Discontinued in Phase 2 Small molecular drug [22]
Elzasonan hydrochloride DM1EOC3 Discontinued in Phase 2 Small molecular drug [5]
LESOPITRON DIHYDROCHLORIDE DMGQJ2U Discontinued in Phase 2 Small molecular drug [23]
MCPP DMIG5W8 Discontinued in Phase 2 Small molecular drug [24]
PRX-00023 DMN4RV0 Discontinued in Phase 2 Small molecular drug [5]
R-1578 DMAPRGQ Discontinued in Phase 2 NA [25]
SPD-473 DMTJNRL Discontinued in Phase 2 NA [26]
Lu-AA44608 DMH0AMG Discontinued in Phase 1 NA [27]
MOXIFETIN HYDROGEN MALEATE DMO2S6T Terminated Small molecular drug [29]
------------------------------------------------------------------------------------
⏷ Show the Full List of 16 Drug(s)
This Disease is Treated as An Indication in 2 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
CKI-7 DMV0RFU Preclinical Small molecular drug [28]
LH846 DMJXZIS Preclinical Small molecular drug [28]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 150 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
AR TTKPW01 Limited Biomarker [30]
ATP2A2 TTE6THL Limited Genetic Variation [31]
CD9 TTZEIBV Limited Altered Expression [32]
CRY2 TTAO58M Limited Biomarker [33]
CYP2D6 TTVG215 Limited Genetic Variation [34]
DRD1 TTZFYLI Limited Altered Expression [35]
GAD1 TTKGEP3 Limited Biomarker [36]
GAD2 TT7UY6K Limited Biomarker [37]
GAL TTXZAJ5 Limited Biomarker [38]
GRIK2 TT0K5RG Limited Biomarker [39]
GRM3 TT8A9EF Limited Biomarker [40]
HCRTR1 TT60Q8D Limited Genetic Variation [41]
HTR3A TTPC4TU Limited Biomarker [42]
HTR6 TTJS8PY Limited Biomarker [43]
MAPKAP1 TTWDKCL Limited Genetic Variation [44]
NTF3 TTZHKV9 Limited Biomarker [45]
PBRM1 TTH8ZRL Limited Genetic Variation [46]
PDE4B TTVIAT9 Limited Genetic Variation [47]
PRL TTJ2TSA Limited Biomarker [48]
PTH2R TTEPJL5 Limited Genetic Variation [47]
SERPINA1 TTA7UJC Limited Altered Expression [49]
SLC6A2 TTAWNKZ Limited Biomarker [50]
ADORA2A TTM2AOE moderate Genetic Variation [51]
ADRA1B TTBRKXS moderate Biomarker [52]
ADRA2A TTWG9A4 moderate Biomarker [52]
ADRA2C TT2NUT5 moderate Biomarker [52]
ARRB2 TT8SO2I moderate Biomarker [53]
CACNA1D TT7RGTM moderate Biomarker [54]
CHRM2 TTYEG6Q moderate Biomarker [55]
CRH TTA7YIZ moderate Biomarker [56]
DBH TTYIP79 moderate Biomarker [57]
ESR1 TTZAYWL moderate Genetic Variation [58]
FKBP5 TT0J5KQ moderate Biomarker [59]
FTO TTFW3BT moderate Biomarker [60]
GABRB2 TTZA1NY moderate Biomarker [61]
GABRD TTGXH6N moderate Biomarker [62]
GAP43 TTSGLN5 moderate Biomarker [63]
GLUL TTURQ2G moderate Biomarker [64]
HDAC1 TT6R7JZ moderate Biomarker [65]
HDAC2 TTSHTOI moderate Biomarker [65]
HDAC4 TTTQGH8 moderate Biomarker [66]
HP TTLC8E1 moderate Altered Expression [49]
HPGDS TTCYE56 moderate Biomarker [67]
HTR1B TTK8CXU moderate Biomarker [68]
HTR4 TT07C3Y moderate Biomarker [68]
HTR7 TTO9X1H moderate Biomarker [69]
HTT TTIWZ0O moderate Biomarker [70]
KAT2B TTVK7SB moderate Biomarker [71]
KCNK9 TTL4FMB moderate Biomarker [72]
NCAM1 TTVXPHT moderate Genetic Variation [73]
NFKB1 TTUIZKC moderate Biomarker [74]
NTRK3 TTXABCW moderate Biomarker [75]
NTSR1 TTTUMEP moderate Biomarker [76]
OPRK1 TTQW87Y moderate Biomarker [77]
PPARG TTT2SVW moderate Biomarker [78]
RARA TTW38KT moderate Biomarker [79]
RGS6 TTJ96M8 moderate Biomarker [80]
SIRT1 TTUF2HO moderate Biomarker [81]
SLC12A5 TTH6UZY moderate Altered Expression [82]
SLC5A7 TTRV7W3 moderate Biomarker [83]
SLC6A3 TTVBI8W moderate Altered Expression [84]
SST TTWF7UG moderate Biomarker [85]
SSTR3 TTJX3UE moderate Biomarker [86]
TNFSF13B TTWMIDN moderate Biomarker [87]
ABAT TTT2LD9 Strong Biomarker [88]
ADCY1 TTV1ZSQ Strong Genetic Variation [89]
AKT1 TTWTSCV Strong Biomarker [90]
APLNR TTJ8E43 Strong Biomarker [91]
APOH TT2OUI9 Strong Genetic Variation [92]
AVPR1B TTL9MHW Strong Biomarker [93]
BPI TTXCSDR Strong Biomarker [94]
C9orf72 TTA4SHR Strong Genetic Variation [95]
CACNA1C TTZIFHC Strong Biomarker [96]
CCKAR TTCG0AL Strong Biomarker [97]
CRHR1 TT7EFHR Strong Biomarker [98]
CRTC1 TT4GO0F Strong Biomarker [99]
CRTC2 TTFWETR Strong Biomarker [100]
CRY1 TT5MLZR Strong Genetic Variation [101]
CSE1L TTTRULD Strong Genetic Variation [102]
CSNK1E TTA8PLI Strong Genetic Variation [103]
CSNK1G1 TTQR5YD Strong Genetic Variation [73]
DAG1 TT4X7PG Strong Genetic Variation [73]
DCLK2 TTHK3MO Strong Genetic Variation [102]
DLG4 TT9PB26 Strong Biomarker [61]
DNMT1 TT6S2FE Strong Altered Expression [104]
DNMT3B TT6VZ78 Strong Altered Expression [104]
DPP10 TTOVUPC Strong Genetic Variation [102]
DRD3 TT4C8EA Strong Biomarker [105]
ERBB4 TTWALCO Strong Biomarker [106]
FGF2 TTGKIED Strong Biomarker [107]
FKBP4 TTHY0FT Strong Biomarker [108]
GABRA3 TT37EDJ Strong Biomarker [109]
GRIA1 TTVPQTF Strong Biomarker [110]
GRIA3 TT82EZV Strong Biomarker [39]
GRIK4 TTQV6BO Strong Genetic Variation [111]
GRM7 TT0I76D Strong Genetic Variation [112]
GSK3B TTRSMW9 Strong Genetic Variation [113]
HCN1 TTNB6UQ Strong Biomarker [114]
HCN4 TTQP04A Strong Genetic Variation [115]
HIF1A TTSN6QU Strong Biomarker [116]
HPD TT8DSFC Strong Biomarker [117]
HSP90AA1 TT78R5H Strong Biomarker [118]
HTR1F TT0MI3F Strong Genetic Variation [119]
HTR3B TTR6K75 Strong Genetic Variation [120]
LDHA TTW76JE Strong Biomarker [116]
LINGO1 TTZYQ80 Strong Genetic Variation [73]
MAD1L1 TTNE9U7 Strong Genetic Variation [73]
MAPT TTS87KH Strong Genetic Variation [73]
MCHR1 TTX4RTB Strong Biomarker [121]
METAP2 TTZL0OI Strong Biomarker [122]
MTHFR TTQWOU1 Strong Biomarker [123]
NPY TT64REZ Strong Altered Expression [124]
NR1H3 TTECBXN Strong Genetic Variation [73]
NTRK2 TTKN7QR Strong Genetic Variation [125]
PFKFB3 TTTHMQJ Strong Biomarker [116]
PGD TTZ3IFB Strong Biomarker [126]
PLA2G1B TT9V5JH Strong Biomarker [127]
PLCB1 TTLPGU7 Strong Biomarker [128]
PNPLA3 TTEUAEH Strong Genetic Variation [129]
PRKCZ TTBSN0L Strong Genetic Variation [130]
PRNP TTY5F9C Strong Biomarker [131]
PROKR2 TTM67AX Strong Biomarker [132]
PSMB6 TT8EPLT Strong Biomarker [62]
RAPGEF3 TTOE7I0 Strong Altered Expression [133]
RAPGEF4 TTOS63B Strong Genetic Variation [133]
RGS8 TTWME23 Strong Biomarker [134]
SIGMAR1 TT5TPI6 Strong Biomarker [135]
SIRT2 TTLKF5M Strong Biomarker [136]
SLC18A2 TTNZRI3 Strong Biomarker [137]
SLC1A2 TT2F078 Strong Altered Expression [138]
SLC25A4 TTU5A6Q Strong Genetic Variation [139]
SLC40A1 TT6Y1PG Strong Altered Expression [140]
SSTR5 TT2BC4G Strong Genetic Variation [141]
STAB1 TTJFEOC Strong Biomarker [142]
TACR1 TTZPO1L Strong Genetic Variation [143]
TNC TTUCPMY Strong Genetic Variation [102]
VIPR2 TT4O5P0 Strong Genetic Variation [101]
CRHBP TT3PKZE Definitive Biomarker [144]
CRHR2 TTIY658 Definitive Biomarker [145]
GPER1 TTDSB34 Definitive Biomarker [146]
GRIN2B TTN9D8E Definitive Biomarker [147]
HCRT TTU5HJP Definitive Biomarker [148]
NPY2R TTJ6WK9 Definitive Biomarker [149]
NR3C2 TT26PHO Definitive Biomarker [150]
P2RX1 TTJW7B3 Definitive Genetic Variation [151]
P2RX3 TT2THBD Definitive Genetic Variation [151]
P2RX4 TT1NLOA Definitive Genetic Variation [151]
P2RY1 TTA93TL Definitive Genetic Variation [151]
P2RY2 TTOZHQC Definitive Genetic Variation [151]
SMC2 TTS8D17 Definitive Biomarker [152]
------------------------------------------------------------------------------------
⏷ Show the Full List of 150 DTT(s)
This Disease Is Related to 2 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC17A6 DT5LHCR Strong Biomarker [153]
SLC44A5 DTU8NCX Strong Genetic Variation [73]
------------------------------------------------------------------------------------
This Disease Is Related to 7 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
AGMAT DEG5L6E Strong Altered Expression [154]
HINT1 DEWJATF Strong Biomarker [155]
PGM1 DEA3VM1 Strong Genetic Variation [126]
SMOX DEOH5V3 Strong Biomarker [156]
SPR DEJVDAT Strong Genetic Variation [157]
SULT2A1 DE0P6LK Strong Biomarker [158]
SAT1 DEMWO83 Definitive Biomarker [156]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 DME(s)
This Disease Is Related to 163 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ADARB1 OTGKSZEV Limited Biomarker [159]
C1QL1 OTNQ0G3E Limited Biomarker [98]
CHGB OT7SAQT2 Limited Biomarker [160]
CHP1 OTHTXN1A Limited Altered Expression [32]
FXR1 OTEMQ1SR Limited Biomarker [161]
IGSF9B OTNOMYYQ Limited Biomarker [162]
MAP2 OT6UYT3X Limited Biomarker [122]
NRSN1 OT1KKXC8 Limited Altered Expression [32]
PLB1 OTZ6TTYV Limited Genetic Variation [127]
SEMG1 OT6Z4BPQ Limited Biomarker [160]
TMED2 OTBLO7RW Limited Altered Expression [32]
TPPP OTCFMSUF Limited Altered Expression [32]
DEAF1 OTCLX3ZW Disputed Altered Expression [163]
AMBP OTLU8GU8 moderate Biomarker [164]
ANK3 OTJ3IRBP moderate Genetic Variation [165]
BSCL2 OT73V6Y4 moderate Biomarker [78]
DCTN1 OT5B51FJ moderate Biomarker [166]
DISC1 OT43AW4H moderate Genetic Variation [167]
DUSP6 OT4H6RKW moderate Biomarker [168]
FEV OTYEC4IR moderate Genetic Variation [169]
FOSB OTW6C05J moderate Biomarker [170]
GABRA6 OTX4UC3O moderate Biomarker [171]
HES6 OTWO5SCF moderate Genetic Variation [172]
IL9R OTILCLXA moderate Biomarker [173]
NTS OTPGDNQS moderate Biomarker [76]
OXT OT48M72Z moderate Biomarker [174]
PFKL OTVHGAT7 moderate Biomarker [175]
PMCH OT3D9SA4 moderate Biomarker [176]
PNOC OTJEAADN moderate Biomarker [177]
S100A10 OTI71243 moderate Biomarker [68]
ADAMTS6 OTSZE6L4 Strong Genetic Variation [102]
ADCY3 OTGOQM6B Strong Biomarker [178]
ADCY7 OTAWMGP3 Strong Biomarker [179]
ADCY8 OTR1WCZX Strong Biomarker [89]
ADCY9 OT1IZT5K Strong Biomarker [180]
AP2B1 OTL6LZJ4 Strong Biomarker [181]
APBB2 OT1VD51B Strong Genetic Variation [102]
AREL1 OTSYV9R3 Strong Genetic Variation [73]
ARFGAP2 OTIP5ZJ7 Strong Genetic Variation [73]
ARHGAP15 OT9CKHDC Strong Genetic Variation [73]
ARPP21 OTWXZN5I Strong Genetic Variation [73]
ATAD2B OTQMSTTC Strong Genetic Variation [73]
ATF7IP OTU6ZA7F Strong Biomarker [182]
ATP2C1 OTQN51T3 Strong Genetic Variation [183]
ATP5F1A OT3FZDLX Strong Genetic Variation [184]
BAIAP2 OT1KKMYZ Strong Genetic Variation [73]
BAZ1A OTWHOVZS Strong Genetic Variation [102]
BBX OTNQ3QUC Strong Genetic Variation [73]
BHLHE41 OTY9GJ1Y Strong Genetic Variation [102]
BICC1 OTYRKIJ1 Strong Biomarker [185]
BICRA OTDTPGW0 Strong Genetic Variation [102]
CAMK2N2 OT1NDPEL Strong Altered Expression [186]
CAMTA1 OTAN1S5B Strong Genetic Variation [73]
CBFA2T2 OTNOIB23 Strong Biomarker [187]
CCN6 OTRFHQ2Z Strong Biomarker [117]
CCS OTXHT3QO Strong Genetic Variation [188]
CDH8 OTS3SRZ6 Strong Genetic Variation [102]
CDSN OTQW4HV6 Strong Genetic Variation [189]
CELF4 OT4FS4F5 Strong Genetic Variation [73]
CNDP2 OTJR9436 Strong Genetic Variation [190]
CREB3L1 OT2JHIHM Strong Genetic Variation [73]
CRYL1 OT0SJSJM Strong Genetic Variation [191]
CSTF3 OT1Y7B5U Strong Genetic Variation [102]
DCC OT2C1SHW Strong Genetic Variation [73]
DDB2 OTO8HVVB Strong Genetic Variation [73]
DGKG OTBL32T3 Strong Genetic Variation [102]
DLG3 OTH591WK Strong Biomarker [192]
DLX4 OTLWVCN4 Strong Biomarker [193]
DMTN OTDTKPBW Strong Biomarker [194]
DPY19L3 OTM2DHUR Strong Genetic Variation [73]
DTNBP1 OT9UQT2S Strong Genetic Variation [195]
EGFLAM OTACZZJ0 Strong Genetic Variation [102]
ELP1 OTYEWBF7 Strong Biomarker [196]
EMCN OTS03CZC Strong Genetic Variation [73]
EXD2 OTEM0BTG Strong Genetic Variation [73]
EYS OT0NBPL5 Strong Genetic Variation [73]
FAM228B OT26MFMA Strong Genetic Variation [73]
FSTL4 OTTNB9ZP Strong Genetic Variation [102]
FTL OTYQA8A6 Strong Altered Expression [140]
FYB1 OT6345CH Strong Genetic Variation [102]
GABBR1 OTU5A52J Strong Genetic Variation [73]
GCHFR OTEOT8GI Strong Genetic Variation [197]
GNB3 OTA6HYBA Strong Biomarker [198]
GPM6A OT8G13EG Strong Genetic Variation [73]
GPRC5C OT45AJT3 Strong Genetic Variation [199]
HPX OT14T7Q1 Strong Altered Expression [49]
HSPA4 OT5HR0AR Strong Biomarker [200]
ITIH1 OTSXJGQF Strong Biomarker [164]
ITIH3 OT4SLMLY Strong Biomarker [164]
KANSL1 OTYNSNNZ Strong Genetic Variation [73]
KAZN OTPM7BYM Strong Genetic Variation [102]
KCTD12 OTPYKT4Z Strong Biomarker [201]
KLHDC8B OTKP6LCR Strong Genetic Variation [73]
KLHL29 OTS5Z1QN Strong Genetic Variation [73]
LMO3 OTR7AJHN Strong Biomarker [202]
LMOD1 OTZ2MEMG Strong Genetic Variation [73]
LTBP3 OTME98V7 Strong Biomarker [203]
MCIDAS OTK1JVAH Strong Biomarker [204]
NANOS3 OTGX9IQU Strong Biomarker [205]
NAV3 OT97M1TR Strong Genetic Variation [102]
NCOA5 OTOGWTWB Strong Genetic Variation [73]
NEGR1 OT57ECW9 Strong Biomarker [206]
NLK OT2LETFS Strong Genetic Variation [102]
NPAS2 OTMRT2TS Strong Genetic Variation [101]
NRG3 OTIFZ5CT Strong Biomarker [207]
NUP160 OTUKVV3I Strong Genetic Variation [73]
ORM1 OTZKSBRE Strong Genetic Variation [184]
OSR1 OTB19LEQ Strong Biomarker [208]
PAFAH1B1 OT9T2TCJ Strong Genetic Variation [73]
PCDH17 OTRK0M05 Strong Altered Expression [209]
PCLO OTXJZZ98 Strong Genetic Variation [210]
PDYN OTEJ6430 Strong Biomarker [211]
PER3 OTVKYVJA Strong Genetic Variation [212]
PHF2 OTJCIQR2 Strong Genetic Variation [73]
PIK3R2 OTZSUQK5 Strong Biomarker [187]
PLCB4 OTPA0QHW Strong Biomarker [128]
PLCL2 OTK5FDF6 Strong Genetic Variation [73]
PLXNA3 OTMZIBVG Strong Genetic Variation [213]
POLG OTDUCT04 Strong Biomarker [214]
POU3F1 OTYARA94 Strong Biomarker [215]
PPP1R12C OT9Q86JO Strong Biomarker [187]
PPP1R13B OTC88VQO Strong Biomarker [187]
PPP1R1B OTSIJMQ9 Strong Altered Expression [216]
PPP1R9B OTDCTHTT Strong Biomarker [217]
PPP4R3A OTXTCULM Strong Genetic Variation [102]
PROK2 OT70IFEZ Strong Biomarker [218]
PRR16 OTG4TEGR Strong Genetic Variation [73]
PTPRD OTZPJ3GX Strong Genetic Variation [102]
RAB27B OTPF9D0K Strong Genetic Variation [73]
RABEP2 OTO61X27 Strong Biomarker [219]
RABGAP1L OT7QO47I Strong Genetic Variation [73]
RAPSN OTGMSWDQ Strong Genetic Variation [73]
RBFOX1 OTFPKEL7 Strong Genetic Variation [73]
RELN OTLKMW1O Strong Altered Expression [220]
RERE OT3G4GBZ Strong Genetic Variation [73]
RNPS1 OT7G4COD Strong Altered Expression [221]
SEC24C OTMTJBQ1 Strong Genetic Variation [222]
SERTAD1 OTBHKZQP Strong Biomarker [223]
SMS OT8JYKNH Strong Biomarker [224]
SORCS3 OT4VOMBC Strong Genetic Variation [73]
SOX6 OTT0W0LE Strong Genetic Variation [73]
SPSB4 OTG9MLO4 Strong Genetic Variation [102]
SSPN OTYG2SL7 Strong Genetic Variation [102]
ST8SIA2 OTRBBBD8 Strong Biomarker [225]
SYN2 OTK0DEGH Strong Biomarker [226]
TAAR6 OTUBUJ2N Strong Biomarker [200]
TBC1D25 OT11OABF Strong Biomarker [156]
TCF4 OTB9ASTK Strong Genetic Variation [73]
TFAP2D OT71O6YN Strong Genetic Variation [102]
THBS3 OTDKMUBD Strong Biomarker [227]
TIMELESS OTD8DCBJ Strong Genetic Variation [103]
TMEM106B OTUWA6NW Strong Genetic Variation [73]
TOM1 OT30QA56 Strong Genetic Variation [228]
TSNAX OTZ9SGWB Strong Biomarker [229]
TTC12 OTDB24YV Strong Genetic Variation [73]
DGKH OTYNPJ4B Definitive Biomarker [230]
DNASE1L3 OTEUIMC2 Definitive Biomarker [231]
OPN4 OT1LZ7TS Definitive Biomarker [232]
P2RX2 OT0LF34A Definitive Genetic Variation [151]
P2RX5 OTLBR20R Definitive Genetic Variation [151]
P2RX6 OT1FNTXA Definitive Genetic Variation [151]
PVALB OTZW1WVQ Definitive Biomarker [233]
REM1 OTUXL0HC Definitive Biomarker [234]
------------------------------------------------------------------------------------
⏷ Show the Full List of 163 DOT(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8308).
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8182).
3 Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats. Pharmacol Biochem Behav. 2013 Apr;105:41-50.
4 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030225)
5 Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. 2008 Aug;33(9):2080-92.
6 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001264)
7 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6452).
8 ClinicalTrials.gov (NCT01246908) Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression. U.S. National Institutes of Health.
9 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015473)
10 Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study. Aliment Pharmacol Ther.2012 Feb;35(3):360-7.
11 Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder. Drug Des Devel Ther. 2014 Dec 1;8:2321-32.
12 Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007 Sep;12(17-18):757-66.
13 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
14 The Quest for Human Longevity, Lewis D. Solo. Page(145).
15 Phosphodiesterase 2 inhibitors promote axonal outgrowth in organotypic slice co-cultures. Neurosignals. 2013;21(3-4):197-212.
16 ClinicalTrials.gov (NCT00583544) A Safety and Tolerability Single Ascending Dose Study in Healthy Volunteers. U.S. National Institutes of Health.
17 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3219).
18 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 568).
19 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 199).
20 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 108).
21 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009248)
22 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014469)
23 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001441)
24 Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats. Br J Pharmacol. 2011 Apr;162(8):1770-80.
25 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034342)
26 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010517)
27 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025127)
28 Circadian rhythm as a therapeutic target. Nat Rev Drug Discov. 2021 Apr;20(4):287-307.
29 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001731)
30 Direct Involvement of Androgen Receptor in Oxytocin Gene Expression: Possible Relevance for Mood Disorders.Neuropsychopharmacology. 2017 Sep;42(10):2064-2071. doi: 10.1038/npp.2017.76. Epub 2017 Apr 27.
31 Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease.Mol Psychiatry. 2002;7(4):424-7. doi: 10.1038/sj.mp.4000989.
32 Detection of Borna disease virus p24 RNA in peripheral blood cells from Brazilian mood and psychotic disorder patients.J Affect Disord. 2006 Jan;90(1):43-7. doi: 10.1016/j.jad.2005.10.008. Epub 2005 Dec 1.
33 CRY2 genetic variants associate with dysthymia.PLoS One. 2013 Aug 8;8(8):e71450. doi: 10.1371/journal.pone.0071450. eCollection 2013.
34 Analysis of Lithuanian CYP2D6 polymorphism and its relevance to psychiatric care of the local population.Nord J Psychiatry. 2019 Jan;73(1):31-35. doi: 10.1080/08039488.2018.1548648. Epub 2019 Jan 19.
35 Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.Mol Psychiatry. 2014 Dec;19(12):1258-66. doi: 10.1038/mp.2013.165. Epub 2013 Dec 10.
36 Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.J Psychiatry Neurosci. 2011 May;36(3):195-203. doi: 10.1503/jpn.100048.
37 GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders.PLoS One. 2016 Feb 5;11(2):e0148558. doi: 10.1371/journal.pone.0148558. eCollection 2016.
38 GAL3 receptor KO mice exhibit an anxiety-like phenotype.Proc Natl Acad Sci U S A. 2014 May 13;111(19):7138-43. doi: 10.1073/pnas.1318066111. Epub 2014 Apr 29.
39 Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.Neuropsychopharmacology. 2017 Mar;42(4):787-800. doi: 10.1038/npp.2016.149. Epub 2016 Aug 11.
40 Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder.JAMA Psychiatry. 2013 Jun;70(6):591-8. doi: 10.1001/jamapsychiatry.2013.38.
41 Orexin/hypocretin receptor gene (HCRTR1) variation is associated with aggressive behaviour.Neuropharmacology. 2019 Sep 15;156:107527. doi: 10.1016/j.neuropharm.2019.02.009. Epub 2019 Feb 10.
42 Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood.Depress Anxiety. 2010 Aug;27(8):752-9. doi: 10.1002/da.20726.
43 Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis.Neurosci Res. 2010 Jul;67(3):250-5. doi: 10.1016/j.neures.2010.04.003. Epub 2010 Apr 13.
44 Whole Exome Sequencing Identifies a Novel Predisposing Gene, MAPKAP1, for Familial Mixed Mood Disorder.Front Genet. 2019 Feb 15;10:74. doi: 10.3389/fgene.2019.00074. eCollection 2019.
45 Neurotrophin 3 genotype and emotional adverse effects of osmotic-release oral system methylphenidate (OROS-MPH) in children with attention-deficit/hyperactivity disorder.J Psychopharmacol. 2014 Mar;28(3):220-6. doi: 10.1177/0269881113480989. Epub 2013 Mar 7.
46 Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1.Nat Genet. 2010 Feb;42(2):128-31. doi: 10.1038/ng.523. Epub 2010 Jan 17.
47 Genetics of suicide attempts in individuals with and without mental disorders: a population-based genome-wide association study.Mol Psychiatry. 2020 Oct;25(10):2410-2421. doi: 10.1038/s41380-018-0218-y. Epub 2018 Aug 16.
48 Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.Clin Drug Investig. 2020 Jan;40(1):1-14. doi: 10.1007/s40261-019-00854-w.
49 The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder.Mol Neurobiol. 2018 Dec;55(12):8885-8903. doi: 10.1007/s12035-018-1016-x. Epub 2018 Apr 2.
50 Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming.Dev Psychobiol. 2011 Nov;53(7):711-23. doi: 10.1002/dev.20549. Epub 2011 May 5.
51 Association study of adenosine A2a receptor (1976C>T) genetic polymorphism and mood disorders and age of onset.Psychiatr Genet. 2006 Oct;16(5):185. doi: 10.1097/01.ypg.0000218627.26622.eb.
52 Association study of the adrenergic receptors and childhood-onset mood disorders in Hungarian families.Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):227-33. doi: 10.1002/ajmg.b.30292.
53 Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses.Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R209-22. doi: 10.1152/ajpregu.00099.2006. Epub 2007 Mar 15.
54 CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype.Int J Neuropsychopharmacol. 2010 May;13(4):499-513. doi: 10.1017/S1461145709990368. Epub 2009 Aug 11.
55 CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study.Hum Mol Genet. 2005 Aug 15;14(16):2421-34. doi: 10.1093/hmg/ddi244. Epub 2005 Jul 6.
56 (2A)-Adrenergic Receptor Activation Decreases Parabrachial Nucleus Excitatory Drive onto BNST CRF Neurons and Reduces Their Activity In Vivo.J Neurosci. 2019 Jan 16;39(3):472-484. doi: 10.1523/JNEUROSCI.1035-18.2018. Epub 2018 Nov 26.
57 A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.J Neural Transm (Vienna). 2009 Feb;116(2):121-30. doi: 10.1007/s00702-008-0138-0. Epub 2008 Nov 4.
58 Facial Sadness Recognition is Modulated by Estrogen Receptor Gene Polymorphisms in Healthy Females.Brain Sci. 2018 Dec 7;8(12):219. doi: 10.3390/brainsci8120219.
59 Childhood trauma in mood disorders: Neurobiological mechanisms and implications for treatment.Pharmacol Rep. 2019 Feb;71(1):112-120. doi: 10.1016/j.pharep.2018.10.004. Epub 2018 Oct 11.
60 Depressive disorder moderates the effect of the FTO gene on body mass index.Mol Psychiatry. 2012 Jun;17(6):604-11. doi: 10.1038/mp.2011.45. Epub 2011 Apr 19.
61 Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients.J Affect Disord. 2012 May;138(3):494-502. doi: 10.1016/j.jad.2012.01.013. Epub 2012 Feb 21.
62 Association of the GABRD gene and childhood-onset mood disorders.Genes Brain Behav. 2010 Aug;9(6):668-72. doi: 10.1111/j.1601-183X.2010.00598.x. Epub 2010 Jun 18.
63 Early parental deprivation in the marmoset monkey produces long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorder.Neuropsychopharmacology. 2009 May;34(6):1381-94. doi: 10.1038/npp.2008.106. Epub 2008 Jul 9.
64 Gene regulation in the frontal cortex of rats exposed to the chronic mild stress paradigm, an animal model of human depression.Eur J Neurosci. 2008 Apr;27(8):2156-64. doi: 10.1111/j.1460-9568.2008.06155.x. Epub 2008 Mar 25.
65 A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests.PLoS One. 2013 Aug 14;8(8):e71323. doi: 10.1371/journal.pone.0071323. eCollection 2013.
66 Altered gene expression of histone deacetylases in mood disorder patients.J Psychiatr Res. 2010 Apr;44(5):263-70. doi: 10.1016/j.jpsychires.2009.08.015. Epub 2009 Sep 19.
67 Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disorders.Neurosci Lett. 2015 Jan 12;585:132-7. doi: 10.1016/j.neulet.2014.11.002. Epub 2014 Nov 6.
68 Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens.Sci Transl Med. 2010 Oct 20;2(54):54ra76. doi: 10.1126/scitranslmed.3001079.
69 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.Neuropharmacology. 2009 Feb;56(2):448-54. doi: 10.1016/j.neuropharm.2008.09.014. Epub 2008 Oct 7.
70 Huntingtin acts non cell-autonomously on hippocampal neurogenesis and controls anxiety-related behaviors in adult mouse.PLoS One. 2013 Sep 3;8(9):e73902. doi: 10.1371/journal.pone.0073902. eCollection 2013.
71 Alteration of working memory but not in anxiety or stress response in p300/CBP associated factor (PCAF) histone acetylase knockout mice bred on a C57BL/6 background.Neurosci Lett. 2010 May 21;475(3):179-83. doi: 10.1016/j.neulet.2010.03.077. Epub 2010 Apr 4.
72 TASK-3 as a potential antidepressant target.Brain Res. 2011 Oct 6;1416:69-79. doi: 10.1016/j.brainres.2011.08.021. Epub 2011 Aug 16.
73 Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways.Nat Genet. 2018 Jul;50(7):920-927. doi: 10.1038/s41588-018-0151-7. Epub 2018 Jun 25.
74 Regrowing the adult brain: NF-B controls functional circuit formation and tissue homeostasis in the dentate gyrus.PLoS One. 2012;7(2):e30838. doi: 10.1371/journal.pone.0030838. Epub 2012 Feb 1.
75 Association of the neurotrophic tyrosine kinase receptor 3 (NTRK3) gene and childhood-onset mood disorders.Am J Psychiatry. 2008 May;165(5):610-6. doi: 10.1176/appi.ajp.2007.07050805. Epub 2008 Mar 17.
76 Altered sleep and affect in the neurotensin receptor 1 knockout mouse.Sleep. 2012 Jul 1;35(7):949-56. doi: 10.5665/sleep.1958.
77 Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140).J Med Chem. 2019 Feb 28;62(4):1761-1780. doi: 10.1021/acs.jmedchem.8b01679. Epub 2019 Feb 13.
78 Lack of seipin in neurons results in anxiety- and depression-like behaviors via down regulation of PPAR.Hum Mol Genet. 2014 Aug 1;23(15):4094-102. doi: 10.1093/hmg/ddu126. Epub 2014 Mar 20.
79 The involvement of retinoic acid receptor-alpha in corticotropin-releasing hormone gene expression and affective disorders.Biol Psychiatry. 2009 Nov 1;66(9):832-9. doi: 10.1016/j.biopsych.2009.05.031. Epub 2009 Jul 12.
80 Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis.FASEB J. 2014 Apr;28(4):1735-44. doi: 10.1096/fj.13-235648. Epub 2014 Jan 13.
81 Altered sirtuin deacetylase gene expression in patients with a mood disorder.J Psychiatr Res. 2011 Aug;45(8):1106-12. doi: 10.1016/j.jpsychires.2011.01.016. Epub 2011 Feb 23.
82 Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders.J Neurosci. 2012 Apr 11;32(15):5216-22. doi: 10.1523/JNEUROSCI.4626-11.2012.
83 Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: a model of cholinergic capacity limits.Neuropharmacology. 2013 Dec;75:274-85. doi: 10.1016/j.neuropharm.2013.07.032. Epub 2013 Aug 16.
84 Dopamine transporter (DAT) knockdown in the nucleus accumbens improves anxiety- and depression-related behaviors in adult mice.Behav Brain Res. 2019 Feb 1;359:104-115. doi: 10.1016/j.bbr.2018.10.028. Epub 2018 Oct 24.
85 Somatostatin, neuronal vulnerability and behavioral emotionality.Mol Psychiatry. 2015 Mar;20(3):377-87. doi: 10.1038/mp.2014.184. Epub 2015 Jan 20.
86 Long-term alterations to the brain transcriptome in a maternal voluntary consumption model of fetal alcohol spectrum disorders.Brain Res. 2012 Jun 6;1458:18-33. doi: 10.1016/j.brainres.2012.04.016. Epub 2012 Apr 17.
87 Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice.Biol Psychiatry. 2010 Mar 15;67(6):558-66. doi: 10.1016/j.biopsych.2009.12.008.
88 Variants within the GABA transaminase (ABAT) gene region are associated with somatosensory evoked EEG potentials in families at high risk for affective disorders.Psychol Med. 2013 Jun;43(6):1207-17. doi: 10.1017/S0033291711002923. Epub 2012 Jan 9.
89 Genetic markers of comorbid depression and alcoholism in women.Alcohol Clin Exp Res. 2013 Jun;37(6):896-904. doi: 10.1111/acer.12060. Epub 2012 Dec 27.
90 An association of AKT1 gene polymorphism with antidepressant treatment response.World J Biol Psychiatry. 2016 Apr;17(3):239-42. doi: 10.3109/15622975.2015.1112921. Epub 2015 Dec 16.
91 Amelioration of apelin-13 in chronic normobaric hypoxia-induced anxiety-like behavior is associated with an inhibition of NF-B in the hippocampus.Brain Res Bull. 2017 Apr;130:67-74. doi: 10.1016/j.brainresbull.2017.01.005. Epub 2017 Jan 5.
92 Metallomics-based platforms for comparing the human blood serum profiles between bipolar disorder and schizophrenia patients.Rapid Commun Mass Spectrom. 2020 Sep;34 Suppl 3:e8698. doi: 10.1002/rcm.8698. Epub 2020 Feb 18.
93 Association between OPCRIT dimensions and polymorphisms of HPA axis genes in bipolar disorder.J Affect Disord. 2013 Nov;151(2):744-747. doi: 10.1016/j.jad.2013.08.012. Epub 2013 Aug 23.
94 Suggestive linkage of a chromosomal locus on 18p11 to cyclothymic temperament in bipolar disorder families.Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):326-32. doi: 10.1002/ajmg.b.30601.
95 Early onset frontotemporal dementia with psychiatric presentation due to the C9ORF72 hexanucleotide repeat expansion: a case report.BMC Neurol. 2014 Nov 30;14:228. doi: 10.1186/s12883-014-0228-6.
96 CACNA1C risk variant affects microstructural connectivity of the amygdala.Neuroimage Clin. 2019;22:101774. doi: 10.1016/j.nicl.2019.101774. Epub 2019 Mar 12.
97 The unappreciated roles of the cholecystokinin receptor CCK(1) in brain functioning.Rev Neurosci. 2017 Jul 26;28(6):573-585. doi: 10.1515/revneuro-2016-0088.
98 Characterization and gonadal hormone regulation of a sexually dimorphic corticotropin-releasing factor receptor 1 cell group.J Comp Neurol. 2019 Apr 15;527(6):1056-1069. doi: 10.1002/cne.24588. Epub 2018 Dec 24.
99 Gender-specific alteration of energy balance and circadian locomotor activity in the Crtc1 knockout mouse model of depression.Transl Psychiatry. 2017 Dec 8;7(12):1269. doi: 10.1038/s41398-017-0023-4.
100 Deletion of Rictor in catecholaminergic neurons alters locomotor activity and ingestive behavior.Neuropharmacology. 2017 May 1;117:158-170. doi: 10.1016/j.neuropharm.2017.02.001. Epub 2017 Feb 3.
101 Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder.Neuropsychopharmacology. 2010 May;35(6):1279-89. doi: 10.1038/npp.2009.230. Epub 2010 Jan 13.
102 Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.Transl Psychiatry. 2016 Sep 13;6(9):e889. doi: 10.1038/tp.2016.171.
103 Significant role of gene-gene interactions of clock genes in mood disorder.J Affect Disord. 2019 Oct 1;257:510-517. doi: 10.1016/j.jad.2019.06.056. Epub 2019 Jul 2.
104 State-dependent changes in the expression of DNA methyltransferases in mood disorder patients.J Psychiatr Res. 2011 Oct;45(10):1295-300. doi: 10.1016/j.jpsychires.2011.04.008. Epub 2011 May 17.
105 Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder.Psychiatr Genet. 2000 Mar;10(1):43-9. doi: 10.1097/00041444-200010010-00008.
106 Quantification of Tyrosine Hydroxylase and ErbB4 in the Locus Coeruleus of Mood Disorder Patients Using a Multispectral Method to Prevent Interference with Immunocytochemical Signals by Neuromelanin.Neurosci Bull. 2019 Apr;35(2):205-215. doi: 10.1007/s12264-019-00339-y. Epub 2019 Jan 31.
107 Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine.PLoS One. 2018 Oct 1;13(10):e0204980. doi: 10.1371/journal.pone.0204980. eCollection 2018.
108 Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans.PLoS Med. 2014 Nov 11;11(11):e1001755. doi: 10.1371/journal.pmed.1001755. eCollection 2014 Nov.
109 Lack of association between GABRA3 and unipolar affective disorder: a multicentre study.Int J Neuropsychopharmacol. 2001 Sep;4(3):273-8. doi: 10.1017/S1461145701002449.
110 Impact of adolescent GluA1 AMPA receptor ablation in forebrain excitatory neurons on behavioural correlates of mood disorders.Eur Arch Psychiatry Clin Neurosci. 2014 Oct;264(7):625-9. doi: 10.1007/s00406-014-0509-5. Epub 2014 Jun 4.
111 A kainate receptor GluK4 deletion, protective against bipolar disorder, is associated with enhanced cognitive performance across diagnoses in the TwinsUK cohort.World J Biol Psychiatry. 2019 Jun;20(5):393-401. doi: 10.1080/15622975.2017.1417637. Epub 2018 Jan 11.
112 Glutamate receptor metabotropic 7 (GRM7) gene polymorphisms in mood disorders and attention deficit hyperactive disorder.Neurochem Int. 2019 Oct;129:104483. doi: 10.1016/j.neuint.2019.104483. Epub 2019 Jun 4.
113 A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and psychopathology: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.J Affect Disord. 2019 Oct 1;257:S0165-0327(19)30593-2. doi: 10.1016/j.jad.2019.05.044. Epub 2019 May 28.
114 Enhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic- and antidepressant-like behaviors.Neuron. 2012 Aug 9;75(3):503-16. doi: 10.1016/j.neuron.2012.05.027.
115 Association of polymorphisms in HCN4 with mood disorders and obsessive compulsive disorder.Neurosci Lett. 2011 Jun 8;496(3):195-9. doi: 10.1016/j.neulet.2011.04.026. Epub 2011 Apr 20.
116 The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:222-9. doi: 10.1016/j.pnpbp.2013.01.003. Epub 2013 Jan 16.
117 Schizotypal and paranoid personality disorder in the relatives of patients with schizophrenia and affective disorders: a review.Schizophr Res. 1993 Dec;11(1):81-92. doi: 10.1016/0920-9964(93)90041-g.
118 FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior.Biol Psychiatry. 2011 Nov 15;70(10):928-36. doi: 10.1016/j.biopsych.2011.07.023. Epub 2011 Sep 10.
119 Association analysis of the 5-HT(6) receptor polymorphism (C267T) in mood disorders.Am J Med Genet. 1999 Dec 15;88(6):601-2.
120 Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression.Biol Psychiatry. 2006 Jul 15;60(2):192-201. doi: 10.1016/j.biopsych.2005.11.008. Epub 2006 Feb 17.
121 The role of melanin-concentrating hormone in energy homeostasis and mood disorders.J Mol Neurosci. 2009 Sep;39(1-2):86-98. doi: 10.1007/s12031-009-9207-6. Epub 2009 May 6.
122 Microtubule associated protein 2 in bipolar depression: Impact of pregnenolone.J Affect Disord. 2017 Aug 15;218:49-52. doi: 10.1016/j.jad.2017.04.024. Epub 2017 Apr 19.
123 Homocysteine and MTHFR C677T polymorphism in children and adolescents with psychotic and mood disorders.Nord J Psychiatry. 2014 Feb;68(2):129-36. doi: 10.3109/08039488.2013.782066. Epub 2013 Apr 16.
124 Neuropeptide Y and representation of salience in human nucleus accumbens.Neuropsychopharmacology. 2019 Feb;44(3):495-502. doi: 10.1038/s41386-018-0230-6. Epub 2018 Oct 2.
125 Tyrosine receptor kinase B gene variants (NTRK2 variants) are associated with depressive disorders in temporal lobe epilepsy.Epilepsy Behav. 2017 Jun;71(Pt A):65-72. doi: 10.1016/j.yebeh.2017.03.030. Epub 2017 May 24.
126 Serum protein and red cell enzyme polymorphisms in affective disorders.Hum Hered. 1978;28(1):41-7. doi: 10.1159/000152929.
127 Genetic association between the phospholipase A2 gene and unipolar affective disorder: a multicentre case-control study.Psychiatr Genet. 2003 Dec;13(4):211-20. doi: 10.1097/00041444-200312000-00004.
128 Molecular cytogenetic interphase analysis of Phosphoinositide-specific Phospholipase C 1 gene in paraffin-embedded brain samples of major depression patients.J Affect Disord. 2012 Jan;136(1-2):177-180. doi: 10.1016/j.jad.2011.07.023. Epub 2011 Aug 31.
129 Patatin-like phospholipase domain-containing protein 3 (PNPLA3): A potential role in the association between liver disease and bipolar disorder.J Affect Disord. 2017 Feb;209:93-96. doi: 10.1016/j.jad.2016.11.035. Epub 2016 Nov 22.
130 Tests of linkage and allelic association between markers in the 1p36 PRKCZ (protein kinase C zeta) gene region and bipolar affective disorder.Am J Med Genet B Neuropsychiatr Genet. 2012 Mar;159B(2):201-9. doi: 10.1002/ajmg.b.32014. Epub 2012 Jan 9.
131 Depressive-like behaviour of mice lacking cellular prion protein.Behav Brain Res. 2012 Feb 14;227(2):319-23. doi: 10.1016/j.bbr.2011.03.012. Epub 2011 Mar 23.
132 SIRT1 gene is associated with major depressive disorder in the Japanese population.J Affect Disord. 2010 Oct;126(1-2):167-73. doi: 10.1016/j.jad.2010.04.003. Epub 2010 May 7.
133 Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac.Transl Psychiatry. 2016 Sep 6;6(9):e881. doi: 10.1038/tp.2016.129.
134 Depression-resistant Phenotype in Mice Overexpressing Regulator of G Protein Signaling 8 (RGS8).Neuroscience. 2018 Jul 15;383:160-169. doi: 10.1016/j.neuroscience.2018.05.005. Epub 2018 May 18.
135 The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder.Adv Ther. 2017 Mar;34(3):713-724. doi: 10.1007/s12325-017-0482-2. Epub 2017 Jan 31.
136 Downregulation of SIRT2 by Chronic Stress Reduces Expression of Synaptic Plasticity-related Genes through the Upregulation of Ehmt2.Exp Neurobiol. 2019 Aug 31;28(4):537-546. doi: 10.5607/en.2019.28.4.537.
137 Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users. Am J Psychiatry. 2003 Jan;160(1):47-55. doi: 10.1176/appi.ajp.160.1.47.
138 Schisantherin B Improves the Pathological Manifestations of Mice Caused by Behavior Desperation in Different Ages-Depression with Cognitive Impairment.Biomol Ther (Seoul). 2019 Mar 1;27(2):160-167. doi: 10.4062/biomolther.2018.074.
139 Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene.Neuromuscul Disord. 2003 Feb;13(2):162-5. doi: 10.1016/s0960-8966(02)00221-3.
140 Aspirin increases ferroportin 1 expression by inhibiting hepcidin via the JAK/STAT3 pathway in interleukin 6-treated PC-12 cells.Neurosci Lett. 2018 Jan 1;662:1-5. doi: 10.1016/j.neulet.2017.10.001. Epub 2017 Oct 4.
141 Novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene associated with bipolar affective disorder.Mol Psychiatry. 2002;7(7):745-54. doi: 10.1038/sj.mp.4001049.
142 Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder.Transl Psychiatry. 2014 Aug 19;4(8):e426. doi: 10.1038/tp.2014.71.
143 Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome.Am J Med Genet B Neuropsychiatr Genet. 2014 Jun;165B(4):373-80. doi: 10.1002/ajmg.b.32241. Epub 2014 May 9.
144 Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in bipolar disorder.Psychiatr Genet. 2007 Oct;17(5):304-7. doi: 10.1097/YPG.0b013e328133f342.
145 Corticotropin-releasing factor receptor antagonists in affective disorders and drug dependence-- an update.CNS Neurol Disord Drug Targets. 2006 Apr;5(2):147-65. doi: 10.2174/187152706776359619.
146 G-1 exhibit antidepressant effect, increase of hippocampal ERs expression and improve hippocampal redox status in aged female rats.Behav Brain Res. 2019 Feb 1;359:845-852. doi: 10.1016/j.bbr.2018.07.017. Epub 2018 Jul 21.
147 Anti-NMDA-receptor antibody in initial diagnosis of mood disorder.Eur Neuropsychopharmacol. 2019 Sep;29(9):1041-1050. doi: 10.1016/j.euroneuro.2019.07.137. Epub 2019 Jul 26.
148 Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:1-7. doi: 10.1016/j.pnpbp.2018.12.008. Epub 2018 Dec 18.
149 Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice.J Mol Neurosci. 2006;28(3):239-45. doi: 10.1385/JMN:28:3:239.
150 Mechanistic Insights in NeuroD Potentiation of Mineralocorticoid Receptor Signaling.Int J Mol Sci. 2019 Mar 29;20(7):1575. doi: 10.3390/ijms20071575.
151 The P2RX7 polymorphism rs2230912 is associated with depression: A meta-analysis.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:272-277. doi: 10.1016/j.pnpbp.2017.11.003. Epub 2017 Nov 7.
152 Self-reported psychosis-like experiences in patients with mood disorders.Eur Psychiatry. 2018 Jun;51:90-97. doi: 10.1016/j.eurpsy.2016.07.005. Epub 2017 Feb 3.
153 Median raphe controls acquisition of negative experience in the mouse.Science. 2019 Nov 29;366(6469):eaay8746. doi: 10.1126/science.aay8746.
154 Evaluation of plasma agmatine level and its metabolic pathway in patients with bipolar disorder during manic episode and remission period.Int J Psychiatry Clin Pract. 2019 Jun;23(2):128-133. doi: 10.1080/13651501.2019.1569237. Epub 2019 May 13.
155 Altered Light Conditions Contribute to Abnormalities in Emotion and Cognition Through HINT1 Dysfunction in C57BL/6 Mice.Front Behav Neurosci. 2018 Jun 8;12:110. doi: 10.3389/fnbeh.2018.00110. eCollection 2018.
156 Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide.PLoS One. 2010 Nov 30;5(11):e15146. doi: 10.1371/journal.pone.0015146.
157 Polymorphisms of sepiapterin reductase gene alter promoter activity and may influence risk of bipolar disorder.Pharmacogenet Genomics. 2009 May;19(5):330-7. doi: 10.1097/fpc.0b013e328328f82c.
158 Alterations in the steroid biosynthetic pathways in the human prefrontal cortex in mood disorders: A post-mortem study.Brain Pathol. 2018 Jul;28(4):536-547. doi: 10.1111/bpa.12548. Epub 2017 Aug 17.
159 A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia.Mol Brain. 2014 Jan 21;7:5. doi: 10.1186/1756-6606-7-5.
160 Mood disorders in first- and second-generation immigrants: systematic review and meta-analysis.Br J Psychiatry. 2017 Mar;210(3):182-189. doi: 10.1192/bjp.bp.116.181107. Epub 2017 Jan 9.
161 Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3 Are Modulators of Anxiety and Glutamatergic Neurotransmission.Front Mol Neurosci. 2018 Apr 12;11:119. doi: 10.3389/fnmol.2018.00119. eCollection 2018.
162 IgSF9b regulates anxiety behaviors through effects on centromedial amygdala inhibitory synapses.Nat Commun. 2018 Dec 20;9(1):5400. doi: 10.1038/s41467-018-07762-1.
163 Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism.J Neurosci. 2006 Feb 8;26(6):1864-71. doi: 10.1523/JNEUROSCI.2643-05.2006.
164 Inter--inhibitor deficiency in the mouse is associated with alterations in anxiety-like behavior, exploration and social approach.Genes Brain Behav. 2019 Jan;18(1):e12505. doi: 10.1111/gbb.12505. Epub 2018 Aug 6.
165 Candidate gene associations with mood disorder, cognitive vulnerability, and fronto-limbic volumes.Brain Behav. 2014 May;4(3):418-30. doi: 10.1002/brb3.226. Epub 2014 Mar 18.
166 DCTN1 mutations in Perry syndrome.Nat Genet. 2009 Feb;41(2):163-5. doi: 10.1038/ng.293. Epub 2009 Jan 11.
167 DISC1 regulates N-methyl-D-aspartate receptor dynamics: abnormalities induced by a Disc1 mutation modelling a translocation linked to major mental illness.Transl Psychiatry. 2018 Sep 6;8(1):184. doi: 10.1038/s41398-018-0228-1.
168 Association study on the DUSP6 gene, an affective disorder candidate gene on 12q23, performed by using fluorescence resonance energy transfer-based melting curve analysis on the LightCycler.Mol Psychiatry. 2000 Sep;5(5):461, 489-94.
169 The expression of the transcription factor FEV in adult human brain and its association with affective disorders.J Neural Transm (Vienna). 2010 Jul;117(7):831-6. doi: 10.1007/s00702-010-0405-8. Epub 2010 May 18.
170 FosB is essential for the enhancement of stress tolerance and antagonizes locomotor sensitization by FosB.Biol Psychiatry. 2011 Sep 1;70(5):487-95. doi: 10.1016/j.biopsych.2011.04.021. Epub 2011 Jun 15.
171 Evidence of association between gamma-aminobutyric acid type A receptor genes located on 5q34 and female patients with mood disorders.Neurosci Lett. 2003 Sep 25;349(1):9-12. doi: 10.1016/s0304-3940(03)00611-6.
172 Expression and association analyses of promoter variants of the neurogenic gene HES6, a candidate gene for mood disorder susceptibility and antidepressant response.Neurosci Lett. 2009 Aug 28;460(2):185-90. doi: 10.1016/j.neulet.2009.05.065. Epub 2009 May 28.
173 Pseudoautosomal gene: possible association with bipolar males but not with schizophrenia.Psychiatr Genet. 1999 Sep;9(3):129-34.
174 No association between oxytocin or prolactin gene variants and childhood-onset mood disorders.Psychoneuroendocrinology. 2010 Oct;35(9):1422-8. doi: 10.1016/j.psyneuen.2010.04.008. Epub 2010 May 23.
175 Linkage study between manic-depressive illness and chromosome 21.Am J Med Genet. 1996 Apr 9;67(2):218-24. doi: 10.1002/(SICI)1096-8628(19960409)67:2<218::AID-AJMG15>3.0.CO;2-M.
176 A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression.Biol Psychiatry. 2007 Jan 15;61(2):174-80. doi: 10.1016/j.biopsych.2006.03.076. Epub 2006 Aug 24.
177 Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats.Psychopharmacology (Berl). 2017 May;234(9-10):1603-1614. doi: 10.1007/s00213-017-4584-y. Epub 2017 Mar 9.
178 Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned.Mol Psychiatry. 2012 Jan;17(1):36-48. doi: 10.1038/mp.2010.109. Epub 2010 Nov 2.
179 Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry.Biol Psychiatry. 2012 Apr 1;71(7):627-32. doi: 10.1016/j.biopsych.2011.11.029. Epub 2012 Jan 20.
180 Molecular analysis, mutation screening, and association study of adenylate cyclase type 9 gene (ADCY9) in mood disorders.Am J Med Genet. 2002 Jan 8;114(1):84-92. doi: 10.1002/ajmg.10117.
181 Gene expression effects of lithium and valproic acid in a serotonergic cell line.Physiol Genomics. 2019 Feb 1;51(2):43-50. doi: 10.1152/physiolgenomics.00069.2018. Epub 2018 Dec 21.
182 The importance of measures of affective temperaments in genetic studies of mood disorders.J Psychiatr Res. 1992 Oct;26(4):257-68. doi: 10.1016/0022-3956(92)90032-j.
183 Hailey-Hailey disease with affective disorder: report of a case with novel ATP2C1 gene mutation.J Dermatol Sci. 2006 Aug;43(2):150-1. doi: 10.1016/j.jdermsci.2006.03.009. Epub 2006 Apr 27.
184 A linkage study of affective disorder with DNA markers for the ABO-AK1-ORM linkage group near the dopamine beta hydroxylase gene.Biol Psychiatry. 1994 Oct 1;36(7):434-42. doi: 10.1016/0006-3223(94)90638-6.
185 Serum BICC1 levels are significantly different in various mood disorders.Neuropsychiatr Dis Treat. 2019 Jan 15;15:259-265. doi: 10.2147/NDT.S190048. eCollection 2019.
186 The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study.J Psychiatr Res. 2018 Jul;102:186-191. doi: 10.1016/j.jpsychires.2018.04.012. Epub 2018 Apr 13.
187 Abnormal G protein alpha(s) - and alpha(i2)-subunit mRNA expression in bipolar affective disorder.Mol Psychiatry. 1998 Nov;3(6):512-20. doi: 10.1038/sj.mp.4000393.
188 High Rates of Psychiatric Comorbidity in Narcolepsy: Findings From the Burden of Narcolepsy Disease (BOND) Study of 9,312 Patients in the United States.J Clin Psychiatry. 2017 Feb;78(2):171-176. doi: 10.4088/JCP.15m10262.
189 Beta-1-adrenergic receptor gene in major depression: influence on antidepressant treatment response.Am J Med Genet B Neuropsychiatr Genet. 2003 Jul 1;120B(1):85-9. doi: 10.1002/ajmg.b.20017.
190 Search for biological/genetic markers in a long-term epidemiological and morbid risk study of affective disorders.J Psychiatr Res. 1984;18(4):425-45. doi: 10.1016/0022-3956(84)90031-1.
191 Modeling Strengthens Molecular Link between Circadian Polymorphisms and Major Mood Disorders.J Biol Rhythms. 2018 Jun;33(3):318-336. doi: 10.1177/0748730418764540. Epub 2018 Apr 3.
192 Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression.Schizophr Res. 2005 Oct 1;78(1):87-93. doi: 10.1016/j.schres.2005.06.012.
193 Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder.Compr Psychiatry. 2016 Apr;66:146-56. doi: 10.1016/j.comppsych.2016.01.009. Epub 2016 Jan 26.
194 A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus.Front Mol Neurosci. 2018 Sep 4;11:312. doi: 10.3389/fnmol.2018.00312. eCollection 2018.
195 Dysbindin (DTNBP1)--a role in psychotic depression?.J Psychiatr Res. 2011 May;45(5):588-95. doi: 10.1016/j.jpsychires.2010.09.014. Epub 2010 Oct 15.
196 A prospective study of bipolar disorder vulnerability in relation to behavioural activation, behavioural inhibition and dysregulation of the Behavioural Activation System.Eur Psychiatry. 2017 Jul;44:24-29. doi: 10.1016/j.eurpsy.2017.03.005. Epub 2017 Mar 31.
197 A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants.Pharmacogenomics J. 2011 Jun;11(3):207-13. doi: 10.1038/tpj.2010.23. Epub 2010 Mar 30.
198 C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder.Biol Psychiatry. 2003 Oct 1;54(7):682-6. doi: 10.1016/s0006-3223(03)00169-0.
199 GPR50 is not associated with childhood-onset mood disorders in a large sample of Hungarian families.Psychiatr Genet. 2007 Dec;17(6):347-50. doi: 10.1097/YPG.0b013e3281ac232f.
200 Investigation of an epistastic effect between a set of TAAR6 and HSP-70 genes variations and major mood disorders.Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):680-683. doi: 10.1002/ajmg.b.31009.
201 Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders.Transl Psychiatry. 2015 Feb 17;5(2):e510. doi: 10.1038/tp.2015.8.
202 Lmo3 deficiency in the mouse is associated with alterations in mood-related behaviors and a depression-biased amygdala transcriptome.Psychoneuroendocrinology. 2020 Jan;111:104480. doi: 10.1016/j.psyneuen.2019.104480. Epub 2019 Oct 19.
203 Artificial Intelligence based facial recognition for Mood Charting among men on life style modification and it's correlation with cortisol.Asian J Psychiatr. 2019 Jun;43:101-104. doi: 10.1016/j.ajp.2019.05.017. Epub 2019 May 11.
204 Altered Intrinsic Coupling between Functional Connectivity Density and Amplitude of Low-Frequency Fluctuation in Mild Cognitive Impairment with Depressive Symptoms.Neural Plast. 2018 May 29;2018:1672708. doi: 10.1155/2018/1672708. eCollection 2018.
205 A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder.Int J Neuropsychopharmacol. 2006 Feb;9(1):13-20. doi: 10.1017/S1461145705005560. Epub 2005 Jun 21.
206 Negr1 controls adult hippocampal neurogenesis and affective behaviors.Mol Psychiatry. 2019 Aug;24(8):1189-1205. doi: 10.1038/s41380-018-0347-3. Epub 2019 Jan 16.
207 Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.Am J Psychiatry. 2017 Mar 1;174(3):256-265. doi: 10.1176/appi.ajp.2016.16060721. Epub 2016 Oct 24.
208 External validation of a bifactor model of oppositional defiant disorder.Mol Psychiatry. 2021 Feb;26(2):682-693. doi: 10.1038/s41380-018-0294-z. Epub 2018 Dec 11.
209 The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders.Mol Psychiatry. 2018 Feb;23(2):400-412. doi: 10.1038/mp.2016.231. Epub 2017 Jan 10.
210 Epistatic interaction of genetic depression risk variants in the human subgenual cingulate cortex during memory encoding.Transl Psychiatry. 2014 Mar 18;4(3):e372. doi: 10.1038/tp.2014.10.
211 The dynorphin/-opioid receptor system and its role in psychiatric disorders.Cell Mol Life Sci. 2012 Mar;69(6):857-96. doi: 10.1007/s00018-011-0844-x. Epub 2011 Oct 16.
212 Clock genes polymorphisms in male bipolar patients with comorbid alcohol abuse.J Affect Disord. 2018 Dec 1;241:142-146. doi: 10.1016/j.jad.2018.07.080. Epub 2018 Jul 31.
213 Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. II. Erythrocyte catechol-O-methyltransferase activity in endogenous depression.Acta Psychiatr Scand. 1983 Feb;67(2):96-100. doi: 10.1111/j.1600-0447.1983.tb06728.x.
214 Enrichment of deleterious variants of mitochondrial DNA polymerase gene (POLG1) in bipolar disorder.Psychiatry Clin Neurosci. 2017 Aug;71(8):518-529. doi: 10.1111/pcn.12496. Epub 2017 Feb 8.
215 Screening for bipolar disorder among migraineurs: the impact of migraine-bipolar disorder comorbidity on disease characteristics.Neuropsychiatr Dis Treat. 2017 Mar 1;13:631-641. doi: 10.2147/NDT.S121448. eCollection 2017.
216 Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.Mol Psychiatry. 2014 Feb;19(2):192-9. doi: 10.1038/mp.2012.174. Epub 2013 Jan 8.
217 CAPON Is a Critical Protein in Synaptic Molecular Networks in the Prefrontal Cortex of Mood Disorder Patients and Contributes to Depression-Like Behavior in a Mouse Model.Cereb Cortex. 2019 Aug 14;29(9):3752-3765. doi: 10.1093/cercor/bhy254.
218 PROKR2 is associated with methamphetamine dependence in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1033-6. doi: 10.1016/j.pnpbp.2010.05.018. Epub 2010 May 24.
219 Variation at the fragile X locus does not influence susceptibility to bipolar disorder.Am J Med Genet. 1994 Jun 15;54(2):141-3. doi: 10.1002/ajmg.1320540209.
220 Interaction of reelin and stress on immobility in the forced swim test but not dopamine-mediated locomotor hyperactivity or prepulse inhibition disruption: Relevance to psychotic and mood disorders.Schizophr Res. 2020 Jan;215:485-492. doi: 10.1016/j.schres.2017.07.016. Epub 2017 Jul 13.
221 Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients.J Affect Disord. 2008 Sep;110(1-2):62-9. doi: 10.1016/j.jad.2008.01.003. Epub 2008 Feb 20.
222 The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C.J Biol Chem. 2011 May 6;286(18):16482-90. doi: 10.1074/jbc.M111.230037. Epub 2011 Mar 17.
223 Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities.Brain Behav Immun. 2013 Jul;31:161-71. doi: 10.1016/j.bbi.2012.10.007. Epub 2012 Oct 12.
224 Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial.BMJ Open. 2017 May 29;7(5):e013587. doi: 10.1136/bmjopen-2016-013587.
225 Identification of sialyltransferase 8B as a generalized susceptibility gene for psychotic and mood disorders on chromosome 15q25-26.PLoS One. 2012;7(5):e38172. doi: 10.1371/journal.pone.0038172. Epub 2012 May 31.
226 DNA hypomethylation of Synapsin II CpG islands associates with increased gene expression in bipolar disorder and major depression.BMC Psychiatry. 2016 Aug 11;16(1):286. doi: 10.1186/s12888-016-0989-0.
227 Discovery of Biomarker Panels for Neural Dysfunction in Inborn Errors of Amino Acid Metabolism.Sci Rep. 2019 Jun 24;9(1):9128. doi: 10.1038/s41598-019-45674-2.
228 Gene-based SNP mapping of a psychotic bipolar affective disorder linkage region on 22q12.3: association with HMG2L1 and TOM1.Am J Med Genet B Neuropsychiatr Genet. 2008 Jan 5;147B(1):59-67. doi: 10.1002/ajmg.b.30574.
229 Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies.Mol Psychiatry. 2010 Aug;15(8):844-9. doi: 10.1038/mp.2009.21. Epub 2009 Mar 3.
230 Mania- and anxiety-like behavior and impaired maternal care in female diacylglycerol kinase eta and iota double knockout mice.Genes Brain Behav. 2020 Mar;19(3):e12570. doi: 10.1111/gbb.12570. Epub 2019 Apr 29.
231 Psychedelic-assisted therapies: The past, and the need to move forward responsibly.Int J Drug Policy. 2019 Aug;70:94-98. doi: 10.1016/j.drugpo.2019.05.019. Epub 2019 May 25.
232 Melanopsin, photosensitive ganglion cells, and seasonal affective disorder.Neurosci Biobehav Rev. 2013 Mar;37(3):229-39. doi: 10.1016/j.neubiorev.2012.12.009. Epub 2012 Dec 31.
233 Chronic Treatment with Fluoxetine or Clozapine of Socially Isolated Rats Prevents Subsector-Specific Reduction of Parvalbumin Immunoreactive Cells in the Hippocampus.Neuroscience. 2018 Feb 10;371:384-394. doi: 10.1016/j.neuroscience.2017.12.020. Epub 2017 Dec 21.
234 Sleep study in Disruptive Mood Dysregulation Disorder and Bipolar children.Actas Esp Psiquiatr. 2017 Jan;45(1):12-20. Epub 2017 Jan 1.